BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37668604)

  • 1. Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry.
    Biester T; Eckert A; Becker M; Boettcher C; Golembowski S; Heidtmann B; Klinkert C; Müther S; Rami-Merhar B; Holl RW
    Diabetes Technol Ther; 2023 Nov; 25(11):774-781. PubMed ID: 37668604
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
    Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
    J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transatlantic HbA
    Hermann JM; Miller KM; Hofer SE; Clements MA; Karges W; Foster NC; Fröhlich-Reiterer E; Rickels MR; Rosenbauer J; DeSalvo DJ; Holl RW; Maahs DM;
    Diabet Med; 2020 May; 37(5):848-855. PubMed ID: 31557351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries.
    Maahs DM; Hermann JM; DuBose SN; Miller KM; Heidtmann B; DiMeglio LA; Rami-Merhar B; Beck RW; Schober E; Tamborlane WV; Kapellen TM; Holl RW; ;
    Diabetologia; 2014 Aug; 57(8):1578-85. PubMed ID: 24893863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are nocturnal hypoglycemia prevention strategies influenced by diabetes technology usage? A BETTER registry analysis.
    Talbo MK; Rabasa-Lhoret R; Yale JF; Peters TM; Brazeau AS
    Diabetes Res Clin Pract; 2022 Sep; 191():110080. PubMed ID: 36099973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry.
    Sandig D; Grimsmann J; Reinauer C; Melmer A; Zimny S; Müller-Korbsch M; Forestier N; Zeyfang A; Bramlage P; Danne T; Meissner T; Holl RW
    Diabetes Technol Ther; 2020 Aug; 22(8):602-612. PubMed ID: 32522039
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries.
    Sherr JL; Hermann JM; Campbell F; Foster NC; Hofer SE; Allgrove J; Maahs DM; Kapellen TM; Holman N; Tamborlane WV; Holl RW; Beck RW; Warner JT;
    Diabetologia; 2016 Jan; 59(1):87-91. PubMed ID: 26546085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic, Clinical, Management, and Outcome Characteristics of 8,004 Young Children With Type 1 Diabetes.
    Sandy JL; Tittel SR; Rompicherla S; Karges B; James S; Rioles N; Zimmerman AG; Fröhlich-Reiterer E; Maahs DM; Lanzinger S; Craig ME; Ebekozien O; ; ;
    Diabetes Care; 2024 Apr; 47(4):660-667. PubMed ID: 38305782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry.
    Kamrath C; Tittel SR; Kapellen TM; von dem Berge T; Heidtmann B; Nagl K; Menzel U; Pötzsch S; Konrad K; Holl RW
    Lancet Child Adolesc Health; 2021 Jan; 5(1):17-25. PubMed ID: 33253630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related differences in metabolic response to continuous subcutaneous insulin infusion in pre-pubertal and pubertal children with Type 1 diabetes mellitus.
    Rabbone I; Bobbio A; Berger K; Trada M; Sacchetti C; Cerutti F
    J Endocrinol Invest; 2007 Jun; 30(6):477-83. PubMed ID: 17646722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion pump treatment in children with type 1 diabetes mellitus.
    Liberatore R; Perlman K; Buccino J; Artiles-Sisk A; Daneman D
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):223-6. PubMed ID: 15055358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
    Heptulla RA; Allen HF; Gross TM; Reiter EO
    Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents.
    Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):198-203. PubMed ID: 33374094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-variate trajectories of metabolic control, body mass index, and insulin dose: Heterogeneous response to initiation of pump therapy in youth with type 1 diabetes.
    Tauschmann M; Schwandt A; Prinz N; Becker M; Biester T; Hess M; Holder M; Karges B; Näke A; Kuss O; von Sengbusch S; Holl RW;
    Pediatr Diabetes; 2022 May; 23(3):330-340. PubMed ID: 35084795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.
    Commissariat PV; Boyle CT; Miller KM; Mantravadi MG; DeSalvo DJ; Tamborlane WV; Van Name MA; Anderson BJ; DiMeglio LA; Laffel LM
    Diabetes Technol Ther; 2017 Jun; 19(6):363-369. PubMed ID: 28581817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.
    Pańkowska E; Szypowska A; Lipka M; Szpotańska M; Błazik M; Groele L
    Pediatr Diabetes; 2009 Aug; 10(5):298-303. PubMed ID: 19175902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.